Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $10605.0.

  • 60 Degrees Pharmaceuticals' Amortizatization of Intangibles rose 271.19% to $10605.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41648.0, marking a year-over-year decrease of 2750.69%. This contributed to the annual value of $38502.0 for FY2024, which is 2307.75% down from last year.
  • As of Q3 2025, 60 Degrees Pharmaceuticals' Amortizatization of Intangibles stood at $10605.0, which was up 271.19% from $10442.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $343510.0 during Q1 2023, with a 5-year trough of -$816036.0 in Q4 2022.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Amortizatization of Intangibles averaged around -$25515.2, with its median value being $10214.0 (2024).
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Amortizatization of Intangibles soared by 53203.78% in 2023, and later tumbled by 9606.5% in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$816036.0 in 2022, then skyrocketed by 103.61% to $29447.0 in 2023, then tumbled by 64.35% to $10498.0 in 2024, then grew by 1.02% to $10605.0 in 2025.
  • Its last three reported values are $10605.0 in Q3 2025, $10442.0 for Q2 2025, and $10103.0 during Q1 2025.